Cases filed in Delaware
Cases 1 - 10 of 48
Vanda Pharmaceuticals, Inc. v. MSN Pharmaceuticals, Inc. et al
as 1:2024cv00505
Plaintiff: Vanda Pharmaceuticals, Inc.
Defendant: MSN Pharmaceuticals, Inc., MSN Laboratories Private Limited, Amneal Pharmaceuticals, Inc. and others
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche
as 1:2024cv00048
Plaintiff: MSN Laboratories Private Limited
Defendant: Bioprojet Societe Civile de Recherche
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Harmony Biosciences, LLC et al v. MSN Pharmaceuticals Inc. et al
as 1:2023cv01420
Plaintiff: Harmony Biosciences, LLC, Bioprojet Socite Civile de Recherche and Bioprojet Pharma SAS
Defendant: MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2023cv01277
Plaintiff: Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan Holdings Unlimited Company et al v. MSN Laboratories Private Limited et al
as 1:2023cv00794
Plaintiff: Allergan Holdings Unlimited Company, AbbVie Inc., AbbVie US LLC and others
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. MSN Laboratories Private Limited et al
as 1:2023cv00699
Plaintiff: Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff: Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant: MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al We have downloadable decisions or orders for this case
as 1:2022cv01395
Plaintiff: Novartis Pharmaceuticals Corporation
Defendant: Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv01388
Plaintiff: ACADIA Pharmaceuticals Inc.
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2022cv01115
Plaintiff: Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant: MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?